Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Jul 5 REGN Swing Trading Regeneron Stock Shows How To Bob And Weave
Jul 5 NVO Study links GLP-1 drugs, metformin to lower risk of certain cancers
Jul 5 NVO Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Jul 5 NVO Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
Jul 5 NVO Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
Jul 5 REGN Dupixent “addresses current gap” in COPD biologics landscape
Jul 5 NVO Is It Too Late to Buy Novo Nordisk Stock?
Jul 5 NVO Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
Jul 4 NVO Novo Nordisk: Buy On Dips
Jul 4 NVO NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 NVO Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags